BioDetection Systems B.V. is a Dutch biotech company providing bioassays based
around its core Chemically Activated Luciferase Expression (CALUX®)
reporter gene technology. CALUX® is
marketed in North Amerca under the BioLuc™ trademark.
BDS’ BioLuc™ bioassays are available for:
•
Dioxins
• Estrogens
• Androgens
• Progestins
Pipeline:
•
Thyroid hormones
• Retinoids
• Immune response
BDS’ dioxins responsive
DR-BioLuc™ is the only bioassay that meets the performance requirements of new
EU food and feed legislation.By mimicking toxicological pathways, BDS'
BioLuc™ bioassays are being used in drug candidate screening and as
substitutes for in-vivo testing.
By mimicking toxicological pathways,
BDS' BioLuc™ bioassays are being used in drug candidate screening and as
substitutes for in-vivo testing.
See www.toxicology.org
for more information about the conference.
<< other articles
| 
